Trial pauses as scientists test new drug duo against blood cancer
NCT ID NCT06112847
Summary
This study is testing whether a combination of two drugs, epcoritamab and lenalidomide, is effective for adults with follicular lymphoma who have not yet received any treatment. The goal is to see if using these drugs together can lead to a complete disappearance of the cancer and control it for a longer time. The trial is currently suspended and is not testing for a cure, as follicular lymphoma is considered a manageable but incurable disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
-
City of Hope at Irvine Lennar
Irvine, California, 92618, United States
Conditions
Explore the condition pages connected to this study.